These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11166877)

  • 21. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of immune responses following antigen administration by mucosal route.
    Medina E; Guzmán CA
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):305-11. PubMed ID: 10727886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.
    Szatraj K; Szczepankowska AK; Chmielewska-Jeznach M
    J Appl Microbiol; 2017 Aug; 123(2):325-339. PubMed ID: 28295939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteria as DNA vaccine carriers for genetic immunization.
    Schoen C; Stritzker J; Goebel W; Pilgrim S
    Int J Med Microbiol; 2004 Oct; 294(5):319-35. PubMed ID: 15532991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new series of mycobacterial expression vectors for the development of live recombinant vaccines.
    Baulard A; Kremer L; Supply P; Vidaud D; Bidart JM; Bellet D; Locht C
    Gene; 1996 Oct; 176(1-2):149-54. PubMed ID: 8918246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK; Srivastava R; Srivastava BS
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity induced by a recombinant BCG vaccine encoding the cyclophilin gene of Toxoplasma gondii.
    Yu Q; Huang X; Gong P; Zhang Q; Li J; Zhang G; Yang J; Li H; Wang N; Zhang X
    Vaccine; 2013 Dec; 31(51):6065-71. PubMed ID: 24176493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.
    Kuczkowska K; Kleiveland CR; Minic R; Moen LF; Øverland L; Tjåland R; Carlsen H; Lea T; Mathiesen G; Eijsink VGH
    Appl Environ Microbiol; 2017 Jan; 83(2):. PubMed ID: 27815271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live-attenuated bacteria as a cancer vaccine vector.
    Toussaint B; Chauchet X; Wang Y; Polack B; Le Gouëllec A
    Expert Rev Vaccines; 2013 Oct; 12(10):1139-54. PubMed ID: 24124876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Horizontal gene transfer of virulence determinants in selected bacterial foodborne pathogens.
    Kelly BG; Vespermann A; Bolton DJ
    Food Chem Toxicol; 2009 May; 47(5):969-77. PubMed ID: 18420327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactic acid bacteria as vaccine delivery vehicles.
    Wells JM; Robinson K; Chamberlain LM; Schofield KM; Le Page RW
    Antonie Van Leeuwenhoek; 1996 Oct; 70(2-4):317-30. PubMed ID: 8879413
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria.
    Mohamadzadeh M; Duong T; Hoover T; Klaenhammer TR
    Expert Rev Vaccines; 2008 Mar; 7(2):163-74. PubMed ID: 18324887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusion of HPV L1 into Shigella surface IcsA: a new approach in developing live attenuated Shigella-HPV vaccine.
    Xu D; Wang D; Yang X; Cao M; Yu J; Wang Y
    Antiviral Res; 2014 Feb; 102():61-9. PubMed ID: 24333518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.